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he present work investigated whether polyamines
play a role in the control of the innate immune response
in the brain. The ﬁrst evidence that these molecules
may be involved in such a process was based on the robust
increase in the expression of the ﬁrst and rate-limiting
enzyme of biosynthesis of polyamines during immune stimuli.
Indeed, systemic lipopolysaccharide (LPS) administration
increased ornithine decarboxylase (ODC) mRNA and protein
within neurons and microglia across the mouse central
nervous system (CNS). This treatment was also associated
with a robust and transient transcriptional activation of genes
encoding pro-inﬂammatory cytokines and toll-like receptor
T
 
2 (TLR2) in microglial cells. The endotoxin increased the
cerebral activity of ODC, which was abolished by a suicide
inhibitor of ODC. The decrease in putrescine levels largely
prevented the ability of LPS to trigger tumor necrosis factor 
 
 
 
and TLR2 gene transcription in the mouse brain. In contrast,
expression of both transcripts was clearly exacerbated in
response to intracerebral spermine infusion. Finally, inhibition
of polyamine synthesis abolished neurodegeneration and
increased the survival rate of mice exposed to a model of
severe innate immune reaction in the CNS. Thus, poly-
amines have a major impact on the neuronal integrity and
cerebral homeostasis during immune insults.
 
Introduction
 
Polyamines, namely putrescine, spermidine, and spermine,
are essential polycations involved in growth and differentia-
tion (Fozard et al., 1980; Tabor and Tabor, 1984; Pegg et
al., 1988). Because high intracellular polyamine levels are
known to be detrimental to cells (Auvinen et al., 1992),
polyamine content needs to be narrowly regulated by bio-
synthesis, degradation, and transport systems. Ornithine
decarboxylase (ODC;* enzyme classification no. 4.1.1.17) is
the first and rate-limiting enzyme in the synthesis of endoge-
nous polyamines. This enzyme catalyzes the conversion of
ornithine into putrescine, which is the precursor for higher
polyamines. The amount of ODC is regulated by various
growth factors and by polyamines at the levels of transcription
(Katz and Kahana, 1987), translation (White et al., 1987),
and degradation (van Daalen Wetters et al., 1989; Murakami
et al., 1992; Matsufuji et al., 1995). Treatment of mammalian
tissues with 
 
D
 
,
 
L
 
-
 
 
 
-difluoromethylornithine (DFMO), an
active-site inhibitor of ODC (Bey et al., 1978; Meyskens
and Gerner, 1999), leads to a decrease in intracellular
polyamine contents (Hillary and Pegg, 2003). Spermidine
and spermine originate from the successive transfers of amino-
propyl moiety of decarboxylated S-adenosylmethionine to
the secondary amines of putrescine. Spermine and spermidine
can be retroconverted in spermidine and putrescine, respec-
tively, by the polyamine interconversion pathway, leading to
the production of oxidative intermediate products such as
3-aminopropanal.
Polyamines are not only involved in growth and differ-
entiation. In the brain, they modulate the gating of 
 
N
 
-methyl-
 
D
 
-aspartate (NMDA) receptors and ion channels (Ficker et
al., 1994; Lopatin et al., 1994; Fakler et al., 1995; Williams,
1997) and are involved in neurodegenerative processes
(Morrison et al., 1998). Moreover, polyamines have recently
been found to alter the inflammatory response in vitro. The
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endotoxin lipopolysaccharide (LPS) is able to increase ODC
mRNA expression in monocytes (Messina et al., 1990), and
spermine inhibits expression of the inducible isoform of ni-
tric oxide synthase in LPS-treated J774.2 macrophages
(Szabo et al., 1994). Intracellular polyamine levels were also
found to alter macrophage-mediated cytotoxicity in vitro
(Tjandrawinata et al., 1994). Furthermore, the release of
pro-inflammatory cytokines by monocytes is inhibited by
spermine in a spermine uptake–dependent mechanism
(Zhang et al., 1999). Spermine can also increase IL-10 syn-
thesis and suppress IL-12p40 and IFN-
 
 
 
 production in
LPS-stimulated macrophages (Hasko et al., 2000).
Spermine is produced at high levels in regenerating tissues
and is released into the extracellular medium during cellu-
lar lysis (Clarke and Tyms, 1991). Such high levels of
polyamines have previously been reported to be toxic for the
brain, especially when oxidative products are generated by
the interconversion pathway (for review see Seiler, 2000).
Independently of the toxicity of its metabolites though, sper-
mine can inhibit in a dose-dependent manner the release of
tumor necrosis factor 
 
 
 
 (TNF-
 
 
 
) in LPS-treated human
monocytes (Zhang et al., 1997). These data indicate that at
least in vitro, spermine has anti-inflammatory properties (for
review see Zhang et al., 2000).
The innate immune system is characterized by an unspe-
cific and rapid response to microbial components as various
as peptidoglycan, lipoproteins, lipoteichoic acid, bacterial
CpG DNA, and also the endotoxin LPS. This latter is a
major glycolipid constituting the outer membrane of gram-
negative bacteria. LPS is well known to activate macro-
phages and trigger the release of pro-inflammatory cyto-
kines as well as arachidonic acid metabolites, and therefore
is widely used as a model to trigger the innate immune sys-
tem (Taveira da Silva et al., 1993). Acute endotoxemia pro-
vokes a sharp and transient induction of pro-inflammatory
signaling events and transcription of genes that encode cy-
tokines, chemokines, enzymes, proteins of the complement
system, and toll-like receptor 2 (TLR2) in the central ner-
vous system (CNS; for review see Nguyen et al., 2002).
Therefore, the goal of the work was to determine whether
polyamines have the ability to modulate the inflammatory
reaction taking place in the brain. The data that a single
systemic bolus of LPS caused a robust increase in ODC
mRNA expression in numerous structures across the brain
suggested a potential role of polyamines in the cascade of
neuroinflammatory events. Then, we used different ap-
proaches and markers to ascertain the critical role of
polyamines in the cerebral innate immunity in vivo. Fur-
thermore, the functional role of polyamines in a model of
neurodegeneration was investigated. Altogether, these data
support a critical role of polyamines in the control of innate
immune response in the brain, which has profound conse-
quences on the neuronal integrity.
 
Results
 
Expression of ODC mRNA and protein in the CNS of 
vehicle- and LPS-treated mice
 
The distribution of ODC mRNA in vehicle-treated animals
is in accordance with a previous report from Kilpelainen et
al. (2000). Fig. 1 depicts representative examples of the pat-
tern of ODC gene expression in the mouse brain. Constitu-
tive mRNA levels were found in the cortex (layers c2 to c6),
ependymal cells lining the walls of lateral ventricles (epd),
Figure 1. Expression of the gene encoding ODC in the mouse brain 
under basal and immune-challenged conditions. These darkfield 
photomicrographs of nuclear emulsion–dipped sections represent 
the hybridization signal of ODC mRNA 24 h after a single systemic 
bolus of lipopolysaccharide (LPS, 1 mg/kg body weight) or the 
vehicle solution (Veh). Please note the widespread distribution of 
ODC transcript across the CNS and the robust increase in the 
expression levels after systemic LPS administration (right column). 
3V, third ventricle; 4V, fourth ventricle; BMA, basomedial nucleus 
of the amygdala; CA1–3, hippocampal areas; chp, choroid plexus; 
CPu, caudate putamen; DG, dentate gyrus; DMH, dorsomedial 
nucleus hypothalamus; epd, ependymal lining cells of ventricle 
walls; Hb, habenula; InC, interstitial nucleus of Cajal; IPR, interpe-
duncular nucleus rostral; MnPO, median preoptic nucleus; MPA, 
medial preoptic area; Pir2, pyriform cortex (pyramidal layer); PVT, 
paraventricular nucleus of the thalamus; PVN, paraventricular 
nucleus of the hypothalamus; SCh, suprachiasmatic nucleus: SON, 
supraoptic nucleus; Rt, reticular nucleus; Tu, olfactory tubercle; 
VmPO, ventromedial preoptic nucleus; VMH, ventromedial nucleus 
hypothalamus. Magnification, 1.65.T
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median preoptic nucleus (MnPO), ventromedial preoptic
nucleus (VmPO), medial preoptic area (MPA), piriform cor-
tex 2 (Pir2), and olfactory tubercle (Tu). Hippocampal
CA1, CA2, CA3, and dentate gyrus (DG) exhibited strong
constitutive mRNA levels, but the signal was barely detect-
able in the basal ganglia and thalamic area. In the latter, the
hybridization signal was positive only in the habenula (Hb),
paraventricular thalamic nucleus (PVT), and reticular nu-
cleus (Rt). On the other hand, numerous nuclei and areas of
the hypothalamus and amygdala contained basal ODC
mRNA levels. The intensity of the message was actually
quite robust in the paraventricular nucleus (PVN), suprachi-
asmatic nucleus (SCh), dorsomedial hypothalamus (DMH),
ventromedial hypothalamus (VMH), and supraoptic nu-
cleus (SON). The transcript was also detected in the choroid
plexus (chp), purkinje cell layer of the cerebellar cortex, and
numerous nuclei and regions of the rostral and caudal me-
dulla (Fig. 1, bottom left).
The hybridization signal was clearly more intense in the
brain of mice that received a single systemic bolus of LPS
(Fig. 1, right column). The increase in ODC mRNA levels
was nevertheless not specific and took place in most of the
constitutively expressing regions, although differences were
noted among animals, nuclei, and regions. The medulla was
particularly sensitive to the treatment and exhibited very
strong expression levels, especially at 24 h after LPS adminis-
tration (Fig. 1, bottom right).
To ascertain the cellular localization of ODC in the un-
treated mouse brain, a multiple labeling approach was per-
formed. As depicted by Fig. 2, the positive signal in both
neuronal and microglial cells was confirmed via triple im-
munohistochemistry labeling and confocal laser scanning
microscopy. Cytoplasmic ODC protein (Fig. 2, green) colo-
calized with the specific marker of neuronal nuclei NeuN
(Fig. 2, blue), which provides the anatomical evidence that
neurons have the ability to produce polyamines. ODC-
immunoreactive cells also colocalized with a marker of mi-
croglial cells, 
 
iba1
 
. (Fig. 2, red). However, ODC
 
 
 
/NeuN
 
 
 
cells were clearly more numerous and widely distributed
than ODC
 
 
 
/
 
iba1
 
 
 
 cells across the cerebral tissue of mice in-
jected systemically with the bacterial cell wall component.
 
ODC activity in the CNS of vehicle- 
and LPS-treated mice
 
The ODC protein is a particular enzyme well known for
its extremely short half-life and its narrowly controlled
transcription, translation, and activity. To ensure that
LPS-induced increase in ODC gene expression was really
associated with putrescine biosynthesis, ODC activity was
measured in one hemisphere of each control and treated
mouse (Fig. 3). In accordance with other reports, a low
level of ODC activity was found in the brain of control
mice (Kilpelainen et al., 2001). Cerebral ODC activity was
not significantly different between control mice and those
that were treated with DFMO. However, ODC activity
was strongly induced by sixfold 3 h after a single systemic
injection of LPS, which indicates that the latter is able to
increase the biosynthesis of putrescine in the brain. The
enzymatic activity was reduced by 50% in mice that had
access to DFMO in their tap water for 2 d before the sys-
temic LPS challenge. These data demonstrate the ability of
DFMO to cross the blood-brain barrier (BBB) and inhibit
the ODC protein within the brain.
Figure 2. Confocal laser scanning 
microscopic image of ODC-immuno-
reactive (ir) signal within neurons and 
microglia in the cerebral cortex. 
Neuronal nuclei were labeled by means 
of a primary antibody directed against 
NeuN and a secondary antibody conju-
gated to Alexa Fluor
® 546 (A and E, blue 
nuclei). The secondary antibody used to 
label ODC was coupled to Cy2 (B and F, 
green), whereas a Cy5 secondary antibody 
was used to bind the primary antibody 
directed against ionized calcium binding 
adaptor molecule 1 (C and G, iba1) ex-
pressed within cells of myeloid lineage 
(red). D is an overlay of A–C. H is an over-
lay of E–G. White arrows show double-
labeled neurons (ODC-ir/NeuN-ir), 
whereas white arrowheads show double-
labeled microglial cells (ODC-ir/iba1-ir).
Figure 3. Effects of LPS and DFMO treatments in the brain ODC 
activity. ODC activity was determined as described in Materials 
and methods. Data are mean   SEM (bars) values of four animals. 
†, significantly different (P   0.005) from all the other groups of mice.T
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Time-related inhibition of TLR2 mRNA by DFMO
 
TLR2 mRNA has previously been reported to be a very sen-
sitive inducible transcript involved in the early innate im-
mune response to microbial challenge, and was therefore
used in this present work as a marker of neuroinflammation.
A single i.p. bolus of LPS caused a strong transcriptional ac-
tivation of TLR2, first within structures devoid of BBB, and
thereafter across deeper parenchymal areas of the brain. In-
Figure 4. Effects of DFMO on the transcriptional activation of TLR2 in the brain of mice challenged systemically with the endotoxin LPS. 
These photomicrographs were taken from mice that had free access to tap water or the suicide inhibitor of ODC DFMO (2% in drinking water) 
for a period of 2 d before the single i.p. LPS bolus. The brightfield images (insets) are the corresponding darkfield photomicrographs of nuclear 
emulsion–dipped sections of mice killed 3 h after the LPS challenge. The plotting graphs of the right column depict the time-related induction 
of the gene encoding TLR2 in each corresponding area, namely subfornical organs (SFO), choroid plexus (chp), leptomeninges, median 
eminence (ME), and area postrema (AP). Please see Materials and methods for the qualitative analysis of the hybridization signal. 3rd V, third 
ventricle; CC, central canal; epc, ependymal cells; fi, fimbria of hippocampus; NTS, nucleus of the solitary tract. Hyphenated lines ( ) represent 
the tap water/LPS group, whereas solid lines ( ) show the data for the DFMO/LPS group of mice.T
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deed, the hybridization signal was rapidly detected in cells
lining the leptomeninges, chp, all the circumventricular or-
gans (CVOs), and along few blood vessels (Fig. 4). Paren-
chymal cells in the regions adjacent to these structures
became gradually positive, and the signal spread across
the cerebral tissue 24 h after LPS injection. Previously, we
have reported that such a migratory-like induction pattern
takes place essentially within macrophages/microglial cells
(Laflamme et al., 2001). Putrescine plays a critical role in
this innate immune response because TLR2 expression levels
were much lower across the cerebral tissue of animals that
had free access to DFMO (2% drinking water) for a period
of 2 d before the systemic LPS challenge. Indeed, TLR2 hy-
bridization signal was higher in all the regions analyzed in
the brain of mice that had tap water instead of DFMO (Fig.
4). Inhibition of ODC by DFMO largely abolished the
spreading of TLR2-expressing cells across the cerebral tissue,
and leptomeninges no longer displayed positive signal in
mice treated with LPS and DFMO at all the times evaluated
in this work. This treatment was also able to significantly
prevent LPS-induced transcriptional activation of the pro-
inflammatory cytokine TNF-
 
 
 
 in regions devoid of BBB as
well as in the brain parenchyma (unpublished data). These
data clearly support the involvement of polyamines in the
control of the innate immune response by microglial cells.
 
Induction of TLR2 and TNF-
 
 
 
 transcripts by 
intracerebroventricular injection of spermine
 
The next series of experiments tested the effects of spermine
on the innate immune response in the CNS. In contrast to
DFMO, intracerebroventricular (i.c.v.) spermine administra-
tion exacerbated the effects of LPS on TLR2 and TNF-
 
 
 
 gene
expression in the mouse brain (Fig. 5). Animals that received
the intracerebral spermine treatment before the systemic LPS
injection exhibited a profound transcriptional activation of
TLR2 in the chp, CVOs, leptomeninges, microcapillaries,
and within small, scattered cells across the cerebral tissue (Fig.
5, second left column). This was also the case for the pro-
inflammatory cytokine TNF-
 
 
 
, especially within small, scat-
tered cells in the brain parenchyma. Indeed, TNF-
 
 
 
–express-
ing cells were clearly more numerous and widely spread
throughout the CNS of mice that were killed 6 h after being
injected with spermine before the endotoxin (right column).
TLR2 and TNF-
 
 
 
 mRNA levels increased by 560 and 35%,
respectively, in response to spermine/LPS treatment when
compared with the signal intensity quantified in the cerebral
tissue of mice challenged only with the bacterial endotoxin
(Fig. 5, bottom). Nevertheless, the polyamine is not by itself
an immune stimulus for microglial cells because the treatment
with spermine alone failed to trigger TLR2 and TNF-
 
 
 
 gene
expression in the mouse CNS (Fig. 5, bottom).
 
Effects of DFMO on the ability of LPS to cross the BBB
 
LPS uptake in brain parenchyma was monitored by immu-
nohistochemistry using an antibody directed against lipid A,
which is the conserved part of the endotoxin. Lipid A im-
munoreactivity remained undetectable in brain parenchyma
of mice that received either vehicle or LPS (Fig. 6, A and C).
This phenomenon was also similar in the CNS of mice that
were pretreated with DFMO (Fig. 6 D), which indicates
that DFMO did not increase or change the permeability of
the BBB to the endotoxin, at least when injected systemi-
cally and as measured by lipid A immunoreactivity. On the
other hand, a very strong immunoreactive signal was de-
tected in the brain of mice that has a single bolus of LPS into
the striatal region (Fig. 6 E). These data provide the evi-
dence that the anti-lipid A antibody was capable of recogniz-
ing the endotoxin within the brain parenchyma.
 
Functional role of polyamines in a model of 
inflammation-induced neurodegeneration
 
To determine whether the ability of polyamines to alter the in-
flammatory response may be associated with functional conse-
quences on the neuronal integrity, mice received a single
systemic injection with the glucocorticoid (GC) receptor in-
hibitor RU486 before an intracerebral bolus of LPS. This treat-
ment is known to cause an exaggerated inflammatory reaction
due to the lack of inhibitory feedback of GCs on microglial
cells, which ultimately leads to neurodegeneration (Nadeau
and Rivest, 2003). Anatomical signs of brain damages were de-
tected 3 d after the dual treatment combining intracerebral
LPS and systemic RU486 (Fig. 7, A and B). Infusion of the en-
dotoxin alone directly into the brain parenchyma failed to pro-
voke neurodegeneration despite the robust and transient innate
immune reaction (Nadeau and Rivest, 2002; unpublished
data). Indeed, brain damages took place only in mice that re-
ceived RU486 before the intracerebral LPS insult (Fig. 7 A,
white area into the dotted-line circle). The fluorochrome Flu-
oro-Jade B (FJB) was also used to determine the extent of the
neurodegenerating area, which can be visualized by the FJB
green staining (Fig. 7 B). Pretreatment with DFMO essentially
abolished the effects of the combined injections of RU486 and
LPS (Fig. 7, C and D). Indeed, the brain of mice that had free
access to DFMO for a period of 2 d before LPS and RU486 in-
sults did not exhibit any signs of neurodegeneration except for
the tract made by the infusion cannula.
In addition to its neuroprotective role, DFMO was able to
increase dramatically the survival rate of mice treated with
RU486/LPS (Fig. 7 E). 66% of the mice survived to this
treatment when they were pretreated with DFMO for 2 d be-
fore surgery (yellow line), whereas most (93%) mice that did
not have access to DFMO died within 2 h in response to the
RU486/LPS treatment (red line). Actually, only one mouse
survived in that group and was used for the histological prep-
arations depicted in Fig. 7, A and B. Inhibition of putrescine
synthesis was able to prevent the neurotoxic effects of an in-
tracerebral LPS infusion in the absence of an appropriate neg-
ative feedback of GCs on the innate immune response in the
CNS. These data provide the first in vivo evidence that
polyamines are essential modulators of the cascade of neu-
roinflammatory events, which may ultimately have profound
impacts on the neuronal elements and the survival of the host
during intracerebral infections by gram-negative bacteria.
 
Discussion
 
This is the first paper investigating the role of polyamines in
the brain in vivo in a neuroinflammatory context. Here, weT
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Figure 5. Exacerbation of the innate immune response by i.c.v. spermine administration. Mice received a 100-nmol i.c.v. bolus of spermine 
or vehicle solution 5 min before the i.p. LPS challenge, and were killed 6 h after injection time. The brightfield images (insets) are the 
corresponding darkfield photomicrographs of nuclear emulsion–dipped sections hybridized with either toll-like receptor 2 (TLR2) or tumor 
necrosis factor   (TNF- ) cRNA probe. Please note the robust and widespread hybridization signal for both transcripts in the brain of mice 
that received both i.c.v. spermine and i.p. LPS. The plotting graphs depict the semi-quantitative analysis of hybridization signal performed as 
described in Materials and methods. Data are means (  SEM) percentage of the control group (vehicle i.c.v/vehicle i.p.). BV, blood vessels; 
AP, area postrema; ME, median eminence; SFO, subfornical organ. †, significantly different (P   0.05) from the other groups. ††, significantly 
different (P   0.05) from both groups of vehicle-treated mice.T
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show that polyamines are involved in the control of the in-
nate immune system in the CNS and may have a determi-
nant impact on the inflammatory events that take place dur-
ing bacterial infection. Indeed, a single systemic injection
with a cell wall component derived from gram-negative bac-
teria caused robust increase in the gene encoding the first and
rate-limiting enzyme of endogenous synthesis of polyamines.
The increase in ODC mRNA expression is in agreement
with a previous paper that found up-regulation of ODC
transcription in monocytic cells exposed to LPS (Zheng et
al., 1991). We use this model of systemic endotoxemia be-
cause it has the ability to increase the innate immune re-
sponse in the brain, which is associated with transcriptional
activation of numerous pro-inflammatory genes in microglial
cells (Nadeau and Rivest, 2000, 2001; Laflamme and Rivest,
2001; Laflamme et al., 2001; Nguyen et al., 2002).
ODC is narrowly regulated at the level of transcription,
translation, and post-translation (Katz and Kahana, 1987;
White et al., 1987; van Daalen Wetters et al., 1989; Matsufuji
et al., 1995). Therefore, changes in mRNA levels may not re-
flect increase in ODC activity and polyamine biosynthesis in
the cerebral tissue of LPS-treated mice. The presence of anti-
zyme (Kilpelainen et al., 2000), the inhibitor of ODC, could
also restrain the biosynthesis of polyamines in the brain.
However, ODC activity was strongly induced in the brain of
LPS-injected mice, which provides compelling evidence that
this immune challenge is not only capable of triggering ODC
transcription, but also putrescine biosynthesis within the cere-
bral tissue. Moreover, the ability of DFMO to alter both
ODC activity and innate immune response to LPS indicates
that polyamine biosynthesis is indeed taking place in the cere-
bral environment. The fact that intracerebral spermine infu-
sion was able to exacerbate the effects of LPS adds further evi-
dence that spermine, the most downstream polyamine from
putrescine, is involved in the control of the inflammatory re-
sponse in the CNS. It is interesting to note that the effects of
DFMO on brain ODC activity were found only in LPS-chal-
lenged mice. Basal ODC activity is usually extremely low in
the adult mouse CNS (2.83 
 
 
 
 0.71 pmol CO
 
2
 
 per h and per
mg protein; Kilpelainen et al., 2001), and ODC assay was
performed with a protocol designed originally for ODC activ-
ity in the prostate, the tissue that exhibits the highest ODC
activity under basal conditions (Kilpelainen et al., 2001). In
the present method, ODC activity was close to the limit of
quantification in the brain of control mice, but DFMO had
clear effects on the enzyme activity in LPS-challenged ani-
mals. This is nonetheless not surprising because DFMO has
been widely used as an ODC inhibitor, which usually leads to
a complete depletion of putrescine contents as well as a signif-
icant decrease in spermidine and spermine levels (Gilad and
Gilad, 2002; Hillary and Pegg, 2003).
Then, we verified whether microglial cells that are the resi-
dent macrophages of the brain were also capable of express-
ing ODC in response to the endotoxin. This was confirmed
by multiple labeling and confocal microscopy approaches,
and it is clear from these data that circulating LPS increases
ODC gene expression within neurons and microglial cells.
These data provide anatomical evidence that although regu-
lation of gene encoding ODC takes place within neurons
and microglia, pro-inflammatory transcripts are up-regulated
essentially within microglia. These cells play a critical role in
the control of the innate immune response, and are under
the control of polyamines because the suicide inhibitor of
ODC DFMO significantly prevented the increase in TLR2
and cytokine mRNA levels in response to circulating LPS.
Although TLR2 is the receptor that recognizes gram-positive
bacteria, its promoter is very sensitive to ligands that trigger
nuclear factor kappa B signaling, and LPS has the ability to
increase TLR2 transcription first within structures devoid of
BBB and thereafter in microglial cells across the brain paren-
chyma (Laflamme et al., 2001; Nguyen et al., 2002). The
fact that DFMO dramatically inhibited the effects of LPS on
TLR2 and cytokine gene expression in all these regions indi-
cates that decrease in putrescine levels is a profound endoge-
nous anti-inflammatory mechanism in the brain.
The present data supporting that polyamines act as pro-
inflammatory molecules are in disagreement with in vitro re-
ports in which spermine was found to inhibit cytokine syn-
thesis in macrophages in culture (Zhang et al., 1997, 1999,
2000). However, this discrepancy can be explain by the fact
that the present experiments were performed in an in vivo
model in the brain where microglial cells, the CNS resident
macrophages, are in narrow paracrine relationships with
other cells, such as astrocytes and neurons. Another major
difference is that unlike in vivo, LPS may not be eliminated
in culture, and chronic exposure to the endotoxin is known
to cause tolerance of immune cells to this ligand (Nomura et
al., 2000). Tolerant macrophages may behave quite differ-
ently to polyamines from parenchymal microglia that were
activated in an acute manner in the present work.
The mechanism mediating the effects of circulating LPS
on ODC induction across the cerebral elements remains un-
Figure 6. Inhibition of ODC does not alter the entry of LPS in brain parenchyma. Animals had free access to tap water (A, C, and E) or 
DFMO (2% in drinking water, B and D) for a period of 2 d before the systemic LPS (C and D) or saline (A and B) injection. The endotoxin was 
also injected directly within the mouse dorsal basal ganglia as positive control (E). Brains were collected 3 h after the injections and processed 
for immunohistochemistry. Anti-lipid A antibody was used as marker for the conserved part of LPS (green). Please note the strong immunoreactive 
signal only in the brain of the mouse that was administered with the endotoxin directly into the cerebral tissue, whereas no signal was found 
in the parenchymal brain of mice that had access or not to DFMO in their tap water and challenged with LPS i.p. Exposure time, 9 s. Bar, 50  m.T
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clear at this point. Immunohistochemistry was performed to
label lipid A, which is the conserved part of LPS. The latter
was not detectable in the parenchymal brain of mice that re-
ceived a single i.p. bolus of LPS, and DFMO did not affect
the entry of LPS across the BBB. Therefore, it seems that
LPS is not directly responsible to trigger ODC activity in
parenchymal elements of the brain, but this phenomenon
may be attributable to intermediate factors. Indeed, produc-
tion of TNF-
 
 
 
 by cells of the chp and CVOs may be a deter-
minant endogenous mechanism involved in this process.
Microglial TNF-
 
 
 
 acts as an autocrine and paracrine factor
to trigger the inflammatory reaction in the CNS during en-
dotoxemia (Nadeau and Rivest, 2000; Nguyen et al., 2002),
and this elegant mechanism is likely to explain the effects of
circulating LPS on ODC in the CNS. However, we have yet
to provide direct evidence supporting this cascade of events.
This issue regarding whether circulating LPS and other
pathogen-associated molecular patterns have the ability to
Figure 7. Inhibition of ODC prevents cerebral 
damages and increases survival rate of mice that 
received a systemic administration with the GC 
receptor inhibitor RU486 before the intracerebral 
LPS infusion. A–D are from mice killed 3 d after the 
intracerebral LPS infusion (2.5  g/1  l sterile saline 
solution) and the systemic treatment with RU486 (50 
mg/kg per 100  l DMSO). Animals had free access 
to tap water (A and B) or DFMO (2% in drinking 
water, C and D) for a period of 2 d before the intra-
cerebral LPS injection. Please note the degenerating 
area in the brain of the mouse that had only access 
to tap water before RU486 and LPS insults (A and B), 
and that DFMO essentially abolished these effects 
(C and D). Nissl stain and fluorochrome Fluoro-Jade 
B (green area) were used to label the degenerating 
neurons. E depicts the survival curve of mice in 
response to the different treatments. Some treatments 
are represented by the same color because the 
survival rate was identical among these groups of 
mice. Please note that most mice died after being 
injected with RU486 and LPS (red line), whereas 
the majority of mice that were treated with the 
inhibitor of ODC survived to the insults. 100% 
signifies no death; n represents the total number of 
mice used for a given treatment. cc, corpus callosum; 
CPu, caudate putamen.T
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reach parenchymal elements of the brain still remains a matter
of controversies. Injection with the bacterial endotoxin has
been shown to cause a 36% increase in ion permeability of the
BBB (Dyatlov et al., 1998) and elicit gaps between brain mi-
crovasculature endothelial cells with bulging of nuclear zones
and increased numbers of vesicular Golgi complexes and ER
(Persidsky et al., 1997). Lustig and colleagues have also re-
ported that LPS can contribute to virus penetration from the
blood into the CNS, a process that turns a mild viral infection
into a severe lethal encephalitis caused by injury to cerebral
microvasculature endothelium and modulation of BBB per-
meability (Lustig et al., 1992). In contrast, an opening of the
BBB was observed during cerebral inflammatory responses
(allergic encephalomyelitis), but not after LPS administration
(de Vries et al., 1995). Despite the fact that LPS decreases en-
dothelial resistance that may lead to enhanced transport of
low and high mol wt molecules, whether the endotoxin can
easily diffuse through the BBB and whether it can reach deep
parenchymal brain are still open questions, and such a mecha-
nism was not supported by the present paper.
Polyamines have the ability to modulate the immune re-
sponse only in the presence of LPS, and spermine alone is un-
able of mimicking the effects of the endotoxin. Therefore,
polyamines are not direct ligands for activating pro-inflamma-
tory signaling and gene expression by microglial cells, at least
in the present model. The brains of animals that received
DFMO or spermine alone were comparable to those of vehi-
cle-treated mice. However, polyamines seem required to
transduce the secondary signal-taking place across microglial
cells of LPS-treated mice. How then, do polyamines modulate
the innate immune response in the CNS? They may directly
alter LPS-induced signal transduction and gene expression in
microglial cells (Fig. 8, model 1). Alternatively, spermine orig-
inating from neurons and microglia could exert toxic effects
either by the formation of oxidative products along the inter-
conversion pathway (Fig. 8, model 2 A) and/or by an excito-
toxic processes via overactivation of NMDA receptors (Fig. 8,
model 2 B). Both cases would lead to an early innate immune
reaction and gene expression by microglial cells. Another pos-
sibility would be the ability of extracellular spermine to act di-
rectly on microglial cells via the polyamine transport system
(Fig. 8, model 2 C) and to modulate the transcription of early
genes involved in the control of the innate immune system.
The physiological relevance of such interaction between
polyamines and the innate immune system in the brain has
yet to be clearly established. Increase in polyamine metabo-
lism was found to be neurotoxic via glutamate-induced exci-
totoxic events and oxidative by-products originating from
the polyamine interconversion pathway (Porcella et al.,
1991). In contrast, this pathway may play a critical role in
Figure 8. Illustration depicting various hypothetical pathways by which polyamines may interact directly or indirectly with microglial 
cells to modulate the innate/inflammatory response in the CNS. Model 1, LPS induces ODC expression in microglial cells, which leads to an 
increase of intracellular polyamine (PA) concentrations to a level required for TLR2 induction. Model 2, LPS induces neuronal ODC expression 
and increases PA levels. DFMO inhibits ODC activity, which leads to a decrease in putrescine levels. PAs are released in the extracellular 
compartment and exacerbate LPS-induced TLR2 transcription in microglia by three potential pathways. (A) Interconversion of PAs and generation 
of oxidative by-products. (B) Excitotoxicity mediated via PA-activated NMDA receptors. (C) Direct interaction in microglial cells subsequent 
to PA internalization via PA transport systems. Please see Discussion for details.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
266 The Journal of Cell Biology 
 
|
 
 
 
Volume 162, Number 2, 2003
 
neuronal survival after cerebral ischemia (Gilad and Gilad,
1988). Spermine is also able to act as a free radical scavenger
(Ha et al., 1998), which could be a neuroprotective mecha-
nism in the presence of free radicals in the cerebral environ-
ment. It is also possible that ODC contributes to the growth
and plasticity of specific groups of neurons because poly-
amines are involved in the development of the CNS
(Shimizu et al., 1965) and of axonal regeneration after injury
(Cai et al., 2002). Nevertheless, it remains unclear why
ODC expression levels are high in some groups of neurons
and undetectable in others, such as the basal ganglia.
To understand the functional role of polyamines in the
CNS as being neurotoxic and/or neuroprotective molecules,
we used a model of neurodegeneration caused by an exagger-
ated inflammatory response. GCs are probably the most pow-
erful endogenous immunosuppressors, especially for the innate
immune response and the subsequent inflammatory reaction
(McKay and Cidlowski, 1999). Indeed, GCs are potent inhib-
itors of transcription of genes encoding most of the proteins
involved in the innate immune system, and a large body of ev-
idence suggests that nuclear factor kappa B is a key step in this
process (McKay and Cidlowski, 1999). Altogether, these ef-
fects of GCs ultimately lead to a decrease in pro-inflammatory
signal transduction pathways and gene expression, which is an
essential endogenous mechanism to avoid exaggerated re-
sponses during immunogenic challenges. As expected, the in-
flammatory response lasted longer in the brain of animals that
received the GC receptor antagonist RU486 before the intra-
cerebral LPS infusion (Nadeau and Rivest, 2002). Surprisingly,
a single bolus of LPS caused a rapid and severe neurodegenera-
tion only in RU486-pretreated animals (Nadeau and Rivest,
2003). This was also the case in the present work because no
sign of degeneration was found in the brain of mice challenged
intracerebrally with LPS and vehicle i.p., but the endotoxin
became highly neurotoxic in mice treated with RU486. In this
model, the stress was so intense that most of mice died within
2 h after LPS infusion; the only surviving mouse exhibited ma-
jor neuronal damages at the site of LPS administration. The
decrease in putrescine levels by DFMO before the RU486/
LPS cotreatment was able to increase the survival rate from 7
to 66%, and was able to protect LPS-induced neurodegenera-
tion due to inhibition of GC receptors in the brain. Therefore,
polyamines are powerful neurotoxic molecules in this model of
exaggerated innate immune reaction.
In conclusion, polyamines play a major role in the control of
the cerebral innate immune response during microbial chal-
lenges. These data may have a major clinical impact and sug-
gest DFMO as a potential therapeutic drug to restrain neuro-
degeneration in brain disorders associated with inflammation.
The exact mechanisms involved with the cytotoxic effects of
polyamines still need to be firmly established, but the ability of
DFMO to prevent LPS-induced TNF-
 
 
 
 and the critical role
of this cytokine in the LPS/RU486 model (Nadeau and
Rivest, 2003) lead to this direction for future investigations.
 
Materials and methods
 
Animals
 
136 adult male CD1 mice (
 
 
 
25–30 g; Charles River Canada) were accli-
mated to standard laboratory conditions (14 h light/10 h dark cycle, lights
on at 06.00 and off at 20.00) and were given free access to chow and wa-
 
ter. Animal breeding and experiments were conducted according to the
Canadian Council on Animal Care guidelines, as administered by the La-
val University Animal Care Committee.
 
Experimental protocols
 
The first experiment was performed to determine the expression pattern of
the gene encoding ODC in the brain of mice under basal and immune-
challenged conditions. To this end, mice received a single i.p. bolus of ei-
ther 1 mg/kg LPS (from 
 
Escherichia coli,
 
 serotype 055:B5, lot 58H4076;
Sigma-Aldrich) or vehicle solution (100 
 
 
 
l sterile, pyrogen-free saline), and
were killed 1.5, 3, 6, and 24 h afterward as explained below. A second
group of animals was pretreated with the suicide inhibitor of ODC DFMO
(Ilex Oncology) for 48 h. The drug was diluted at a concentration of 2% in
the drinking water, whereas the control group had access to tap water. 2 d
after the beginning of the treatment, both groups were injected with either
sterile saline or LPS and killed at numerous times after injection.
The third group of mice was temporarily anesthetized via an i.p. injec-
tion of a mixture of ketamine hydrochloride, xylazine, and sterile pyrogen-
free saline (1.5:0.5:8.5 vol/vol/vol). The right ventricle was reached stereo-
taxically using the Paxinos and Franklin Atlas (David Kopf Instruments).
With the incisor bar placed 2 mm below the interaural line (horizontal
zero), the coordinates from bregma for the injection cannula were 0 mm
anteroposterior, 1.1 mm lateral, and 2.4 mm dorsoventral. Thereafter, 100
nmol spermine (lot 126H2615; Sigma-Aldrich) or vehicle solution (pyro-
gen-free, sterile, distilled water) was injected with a cannula (33G; Plastics
One) into the right lateral ventricle in a 1-
 
 
 
l volume over 2 min by means
of a microinjection pump (model A-99; Razel Scientific Instruments). 5
min later, mice were injected with either LPS or vehicle and were killed at
6 h after injection time.
The fourth series of experiments consisted of determining the functional
role of polyamines in a model neurodegeneration provoked by a robust in-
nate and inflammatory response in the CNS. Mice had free access to tap
water or DFMO (2% in drinking water) for a period of 2 d before the surger-
ies. On the day of the experiment, mice received a single i.p. administration
with either the GC receptor antagonist RU486 (50 mg/kg body weight/100
 
 
 
l DMSO) or vehicle (100 
 
 
 
l DMSO). 1 h later, mice were temporarily
anesthetized via an i.p. injection of a mixture of ketamine hydrochloride,
xylazine, and sterile pyrogen-free saline (1.5:0.5:8.5 vol/vol/vol). The right
striatum was reached stereotaxically using the Paxinos and Franklin Atlas
(David Kopf Instruments). With the incisor bar placed 2 mm below the in-
teraural line (horizontal zero), the coordinates from bregma for the infusion
cannula (33G; Plastics One) were 0 mm anteroposterior, 2 mm lateral, and
3 mm dorsoventral. Thereafter, 2.5 
 
 
 
g LPS (from 
 
E. coli
 
, serotype 055:B5,
lot 58H4076; Sigma-Aldrich) or vehicle solution (pyrogen-free sterile saline)
was infused into the right striatum in a 1-
 
 
 
l volume over 2 min by means of
a microinjection pump (model A-99; Razel Scientific Instruments). Animals
were killed 3 or 7 d after the intracerebral infusion. Animals were anesthe-
tized with a mixture of ketamine hydrochloride and xylazine (5:1 vol/vol)
and were rapidly perfused transcardially with 0.9% saline, followed by 4%
PFA in 0.1 M borax buffer (pH 9.5 at 4
 
 
 
C). Brains were removed and pro-
cessed as described previously (Laflamme et al., 2001).
The fifth experiment was performed to verify whether the suicide inhib-
itor of ODC DFMO was efficient in the brain. Animals were pretreated
with 2% DFMO in the drinking water for 48 h, whereas the control group
had free access to tap water. 2 d after the beginning of the treatment, both
groups received a single i.p. bolus with either sterile saline or LPS (1 mg/
kg) and were killed 3 h later. Animals were anesthetized with a lethal mix-
ture of ketamine hydrochloride and xylazine (5:1 vol/vol) and decapitated
for a rapid removal of the brains. Cerebral hemispheres were separated
and snap frozen in liquid nitrogen.
 
Determination of ODC activity
 
The cerebral hemispheres (230–260 mg) were homogenized into 10 ml
ice-cold homogenization buffer (50 mM Tris-HCl, pH 7.3, 50 
 
 
 
M pyri-
doxal phosphate, 1 mM EDTA, and 2.5 mM 
 
DL
 
-dithiothreitol) with a Potter
homogenizer. The homogenates were centrifuged at 25,000 
 
g
 
 for 60 min
at 4
 
 
 
C, and the supernatants were used for the measurement of ODC activ-
ity and protein content. ODC activity was assayed by determining the
amount of 
 
14
 
CO
 
2
 
 released from 
 
L
 
-[1-
 
14
 
C]ornithine as described previously
(Janne and Williams-Ashman, 1971; Marchetti et al., 1988). Protein con-
tents were determined on the cytosolic fraction by the method of Bradford
(1976) using bovine gamma globulin as standard.
 
In situ hybridization and histological procedures
 
Plasmids were linearized and sense and antisense riboprobes were synthe-
sized as described in Table I. Hybridization histochemical localization ofT
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the different transcripts was performed on every twelfth section of the
whole rostrocaudal extent of each brain using 
 
35
 
S-labeled cRNA probes as
described previously (Laflamme et al., 1999). Nissl stain was used as a
general index of cellular morphology, and neuronal death was determined
via the Fluoro-Jade B method (Nadeau and Rivest, 2003).
 
Triple immunofluorescence for confocal laser 
scanning microscopy
 
Mouse anti-neuronal nuclei (NeuN; CHEMICON International), mouse anti-
ionized calcium binding adaptor molecule 1 (
 
iba1
 
; provided by Dr. Yoshi-
nori Imai, National Institute of Neuroscience, Kodaira, Japan), and mouse
ODC (MP16–2; Neomarkers) antibodies were used for the multiple immu-
nohistochemical labeling. In brief, slices from untreated animals were
washed in sterile DEPC-treated 50 mM potassium phosphate-buffered saline
(KPBS) and incubated for 20 h at 4
 
 
 
C with ODC antibody diluted in sterile
KPBS plus 0.4% Triton X-100, 1% BSA (fraction V; Sigma-Aldrich), and
0.25% heparin sodium salt USP. Brain slices were then rinsed in sterile KPBS
and incubated with a mixture of KPBS plus 0.4% Triton X-100, 1% BSA,
0.25% heparin, and secondary antibody (Cy™2-conjugated AffiniPure goat
anti–mouse IgG, H
 
 
 
L, 1:1,500 dilution; Jackson ImmunoResearch Labora-
tories) for 60 min. After several rinses in sterile KPBS, sections were incu-
bated with NeuN and 
 
iba1
 
 antibodies for 20 h at 4
 
 
 
C. Thereafter, slices were
rinsed in sterile KPBS and incubated for 60 min with a mixture of KPBS plus
0.4% Triton X-100, 1% BSA, 0.25% heparin, and secondary antibodies
(Cy™5-conjugated AffiniPure goat anti–rabbit IgG, H
 
 
 
L, 1:1,500 dilution;
Jackson ImmunoResearch Laboratories) and Alexa Fluor
 
®
 
 546–conjugated
goat anti–mouse IgG (H
 
 
 
L, 1:1,000 dilution; Molecular Probes, Inc.). Brain
slices were finally rinsed several times in sterile KPBS, mounted onto gelatin-
coated slides, and coverslipped with a polyvinyl alcohol (Sigma-Aldrich)
mounting medium containing 2.5% 1,4-diazabicyclo(2,2,2)-octane (Sigma-
Aldrich) in buffered glycerol (Sigma-Aldrich).
 
Confocal laser scanning microscopy
 
Confocal laser scanning microscopy studies were performed with an oil
immersion objective (X100 Plan-Apo, NA 1.35, X2 numerical zoom) and a
microscope (BX-61; Olympus). Cy™2, Alexa Fluor
 
®
 
 546, and Cy™5 were
excited sequentially at 488 nm (Ar Ion laser; Melles Griot Laser Group) set
at 35% of maximum laser power, 543 nm (HeNe-G Laser; Melles Griot La-
ser Group) set at 25% of maximum laser power, and 647 nm (HeNe-R La-
ser, Melles Griot Laser Group) set at 25% of maximum laser power, re-
spectively. Emissions from Cy™2-, Alexa Fluor
® 546-, and Cy™5-labeled
antibodies were recorded by photomultipliers preset respectively for EGFP
(green pseudo color), TRITC (blue pseudo color), and Cy™5 (red pseudo
color) fluorescent dyes in Fluoview SV 500 imaging software (Olympus).
13 1- m confocal z-series were acquired for each area and were corrected
by 2 Kahlman low speed scans. Acquired z-series images were then flat-
tened in one image and exported in 24-bit TIFF format. For illustrating pur-
pose, the red, green, and blue channels were subsequently separated from
original picture with Adobe Photoshop
® 7.0 software.
Determination of LPS within the brain parenchyma
Brain sections from the first and second groups of mice treated or not with
either DFMO (2% in drinking water) or LPS i.p. (1 mg/kg body weight)
were washed in KPBS and incubated for 3 h at 37 C with KPBS containing
10% goat serum. Additional tissues from animals that received a single bo-
lus of LPS into the dorsal basal ganglia were used as positive controls. Tis-
sues were thereafter rinsed in KPBS and incubated for 16 h at 4 C with
anti-lipid A antibody (clone 43, lot HM 2046–3422 M11; Cell Sciences),
which was diluted in sterile KPBS (1:1,000) plus 0.4% Triton X-100 and
1% BSA (fraction V; Sigma-Aldrich). Brain slices were subsequently rinsed
in KPBS and incubated with a mixture of KPBS plus 0.02% Triton X-100,
1% BSA, and Alexa Fluor® 488 goat anti–mouse IgG Ab (1:1,500; Molec-
ular Probes, Inc.) for 3 h at 20 C. Tissues were thereafter rinsed in KPBS.
Photomicrographs were taken with the same exposure time (9 s) using a
digital camera (SPOT RT Slider; Diagnostic Instruments) mounted directly
on a microscope (BX-60; Olympus) equipped with an FITC-specific epiflu-
orescence filter and connected to a Macintosh computer (Power Macin-
tosh G4; Apple Computers).
Qualitative analysis
The relative intensity of TLR2 or TNF-  mRNA signals throughout the brain
of each animal was assessed on dipped emulsion slides under microscopic
evaluation, and was graded according to the scale of undetectable (0), low
(1), moderate (2), strong (3), or very strong (4) signal.
Quantitative analysis
Semi-quantitative analysis of the TLR2 and TNF-  mRNA hybridization sig-
nal was performed on nuclear emulsion–dipped slides with a CCD video
camera (Sony) attached to a Bmax optical system (BX-50; Olympus) coupled
to a computer. The refractory density in arbitrary unit (RDAU) of the hybrid-
ization signal was measured under darkfield illumination at a magnification
of 25 using NIH Image software (version 1.61 for Macintosh PPC; Wayne
Rasband, National Institutes of Health, Bethesda, MD). The RDAUs of re-
gions of interest were then corrected for the average background signal by
sampling cells immediately outside the region of interest without positive
hybridization signal. Data are reported as a percentage of control (vehicle
i.p., vehicle i.c.v.) of mean RDAU values (  SEM). Statistical analysis was
performed by ANOVA, followed by a Bonferroni/Dunn test procedure as
post-hoc comparisons with Statview software (version 4.01, Macintosh).
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